|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013216,
umls-concept:C0030705,
umls-concept:C0040808,
umls-concept:C0205179,
umls-concept:C0205263,
umls-concept:C0205390,
umls-concept:C0332283,
umls-concept:C0684249,
umls-concept:C0817096,
umls-concept:C1522449,
umls-concept:C2603343
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2004-3-4
|
|
pubmed:abstractText |
The aim of this study was to determine the role of chemotherapy dose intensity in patients with initially unresectable non-metastatic non-small-cell lung cancer (NSCLC), with survival as primary end point, by testing two different regimens as induction chemotherapy followed by thoracic irradiation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:BerghmansTT,
pubmed-author:CorhayJ-LJL,
pubmed-author:EfremidisAA,
pubmed-author:European Lung Cancer Working Party,
pubmed-author:GinerVV,
pubmed-author:KoumakisGG,
pubmed-author:LafitteJ-JJJ,
pubmed-author:LecomteJJ,
pubmed-author:LothairePP,
pubmed-author:MommenPP,
pubmed-author:NinaneVV,
pubmed-author:PaesmansMM,
pubmed-author:RichezMM,
pubmed-author:SculierJ-PJP,
pubmed-author:ThiriauxJJ,
pubmed-author:Van HouttePP,
pubmed-author:WackenierPP
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
399-409
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14998841-Adult,
pubmed-meshheading:14998841-Aged,
pubmed-meshheading:14998841-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:14998841-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:14998841-Carcinoma, Squamous Cell,
pubmed-meshheading:14998841-Cisplatin,
pubmed-meshheading:14998841-Combined Modality Therapy,
pubmed-meshheading:14998841-Dose-Response Relationship, Drug,
pubmed-meshheading:14998841-Female,
pubmed-meshheading:14998841-Humans,
pubmed-meshheading:14998841-Ifosfamide,
pubmed-meshheading:14998841-Lung Neoplasms,
pubmed-meshheading:14998841-Male,
pubmed-meshheading:14998841-Middle Aged,
pubmed-meshheading:14998841-Mitomycin,
pubmed-meshheading:14998841-Neoplasm Staging,
pubmed-meshheading:14998841-Remission Induction,
pubmed-meshheading:14998841-Survival Rate,
pubmed-meshheading:14998841-Thorax,
pubmed-meshheading:14998841-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancer.
|
|
pubmed:affiliation |
Institut Jules Bordet, Brussels, Belgium. sculier@bordet.be
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Clinical Trial, Phase III
|
